Bayer Expects Consumer Sales to Remain Under Pressure in U.S., China -- Market Talk

Dow Jones03-04

1240 GMT - Bayer's consumer-health sales were held back by weakness in the U.S. and China last year and the German company expects challenges in the unit's two biggest markets to continue for now, division head Julio Triana says in a call with reporters. "In the near term, we expect continued volatility in China and the U.S., with performance likely to contract," Triana says. "Slowing growth and market volatility there could heavily influence our results." Bayer forecasts sales at its consumer-health division to be flat or grow by up to 4% this year when adjusted for currency and portfolio changes. A pick-up in consumer spending in the U.S. and China could leave the higher end of the guidance range within reach, Triana says. Shares fall 3.7%. (adria.calatayud@wsj.com)

 

(END) Dow Jones Newswires

March 04, 2026 07:41 ET (12:41 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment